EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging technologies for rapid phenotypic antimicrobial susceptibility testing of clinical isolates of bacteria

Jacob Rattin iD, Malcolm Boswell, Daniel Rhoads iD

Journal of Clinical Microbiology · 12.11.2025 · 63 (11)

DOI: 10.1128/jcm.00674-25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Microbiology, erschienen am 12.11.2025. Verfasst von Jacob Rattin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Bacteria, Anti-Bacterial Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Providing timely and accurate antimicrobial susceptibility testing (AST) results is a crucial component of clinical microbiology practice. Commercial rapid AST (RAST) is an emerging and quickly expanding area. These phenotypic RAST systems use various novel methods to monitor bacterial growth and replication in order to shorten the duration of time required for testing. Implementation of RAST has the potential to expedite antimicrobial therapeutic optimization, which can improve patient care. This minireview describes the current state of commercial phenotypic RAST including tests designed to report antimicrobial susceptibilities directly from clinical specimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteriaAnti-Bacterial AgentsMicrobial Sensitivity TestsHumansBacterial InfectionsPhenotypeTime Factors

Stichwörter der Autor:innen

antibiotic susceptibility testingblood culturerapid antibiotic susceptibility testing

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
  • Independent MicroDx Consultancy Services, Tucson, Arizona, USA.
  • Department of Pathology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA.
  • Infection Biology Program, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.

ORCID-Profile: Jacob Rattin, Daniel Rhoads

Zitieren

APA

Rattin, J., Boswell, M., & Rhoads, D. (2025). Emerging technologies for rapid phenotypic antimicrobial susceptibility testing of clinical isolates of bacteria. Journal of Clinical Microbiology, 63(11). https://doi.org/10.1128/jcm.00674-25

Vancouver

Rattin J, Boswell M, Rhoads D. Emerging technologies for rapid phenotypic antimicrobial susceptibility testing of clinical isolates of bacteria. Journal of Clinical Microbiology. 2025;63(11). doi:10.1128/jcm.00674-25

BibTeX
@article{Rattin2025,
  author = {Rattin, Jacob and Boswell, Malcolm and Rhoads, Daniel},
  title = {Emerging technologies for rapid phenotypic antimicrobial susceptibility testing of clinical isolates of bacteria},
  journal = {Journal of Clinical Microbiology},
  year = {2025},
  volume = {63},
  number = {11},
  doi = {10.1128/jcm.00674-25}
}
Kostenlos starten →